Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Generic Simvastatin vs ZOCOR in Healthy Thai Volunteers
NCT06178640Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Aug 2024
- Primary completion
- Aug 2024
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of simvastatin in hypercholesterolemia (2 arms), sponsored by International Bio Service. Primary endpoints: Plasma Area Under the Curve (AUC(0 to 48hr)) for Simvastatin Acid, Peak Plasma Concentration (Cmax) of Simvastatin Acid and 2 more. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
simvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT06178640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06178640.